Social Mixer 2024 Singapore
Kenvue promotes Venaig Solinhac to VP global brand lead, baby

Kenvue promotes Venaig Solinhac to VP global brand lead, baby

share on

Consumer health company Kenvue has promoted Venaig Solinhac to the role of vice president global brand lead, baby based in New York City. Solinhac was previously the company's vice president, essential health, of APAC in Singapore.

"After three years in London, two years in South Africa, two years in Turkey and seven years in Singapore, it is time for our family to start a new adventure in New York City," she wrote in a LinkedIn update. 

Don't miss: Watsons partners Kenvue, L’Oréal and P&G to drive sustainability efforts

"I am truly looking forward to help more mums realise the extraordinary power of everyday care and to drive more growth in the baby business with the fabulous baby extended team all around the world," she added. 

Before Kenvue, Solinhac was with food and agri-business, Olam, for over two years. She held the position of senior vice president and CMO of Re-Foods. She had a team of 20 people and according to her LinkedIn post, she was particularly proud of how her team was able to enliven the Re-Foods brand despite the “challenges and headwinds” they encountered.

Prior to her time at Olam, Solinhac gained extensive experience having worked for pharmaceutical manufacturer, GlaxoSmithKline Consumer Healthcare (GSK), for nearly 15 years. She was GSK's chief marketing and digital officers for Southeast Asia and Taiwan markets.

She was driving consumer demand across eight categories which included oral care, vitamins and pain management. The seven Southeast Asia markets she was responsible for include Indonesia, Thailand, Vietnam, Taiwan, Malaysia, Singapore and the Philippines. Solinhac had a team of 25 working with her.

Before this, Solinhac also worked with Heineken where she was a senior brand manager for three years as well as a brand manager at Mondelēz International. 

MARKETING-INTERACTIVE has reached out for more information.

The news comes after Kenvue reportedly said that Johnson & Johnson will sell its remaining 9.5% stake in the company, according to Reuters.

Based on Kenvue stock's last close, the offering of 182.3 million shares will be worth about US$3.75 billion, according to Reuters' calculation.

Join us on 12 June 2024 for an exciting experience as Content360 makes its debut in Malaysia! Brace yourself to join the crème de la crème of the content marketing industry hailing from across the region. Immerse yourself in a dynamic atmosphere, and uncover the latest trends with thought leaders and solution providers from the realm of content.

Related articles:
Johnson & Johnson names new Vision Care marketing lead for 4 regions
J&J's new consumer health biz Kenvue files to become independent firm
Venaig Solinhac joins Johnson & Johnson Consumer Health

share on

Follow us on our Telegram channel for the latest updates in the marketing and advertising scene.

Free newsletter

Get the daily lowdown on Asia's top marketing stories.

We break down the big and messy topics of the day so you're updated on the most important developments in Asia's marketing development – for free.

subscribe now open in new window